Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
Rang in aandelen #41013
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes... Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London.
Aandeelprijs
$0.00185055
Marktkapitalisatie
$48.29K
Verandering (1 dag)
-3.55%
Verandering (1 jaar)
30.31%
Land
GB
Handel Nuformix plc (NFX)

Categorie

Aandelsplitsingen voor Nuformix plc (NFX)
Het aandeel Nuformix plc (symbool: NFX) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Sep 23, 2026.
Eén aandeel NFX dat vóór Sep 23, 2026 werd gekocht, staat nu gelijk aan 0 aandelen NFX.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
1 x2
US
0 -
US
1 x3
AU
0 -
NL
0 -
CH